Any idea why there was so much excitement as evidenced by the price/volume action when the trials were initially approved by the FDA but now that they're about to begin, no one seems to care based on the current price/volume action?
Institutional investors would be just that. Investors. Individual or groups with lots of money are the perpetrators manipulating actc. Right now their goal is to keep the pps depressed frustrating and exhausting weak minded longs and traders. When they decide to turn it the other way, don't be surprised to see them push it to $1+ or $10+. All depends on how greedy they are and what they think they can get away with. The market is gamed and for all the front put up by the SEC. Sooner people recognize this the better off they are. I'd rather encourage both eyes be open than believing otherwise.
ROCKY, you've answered your own question of "where is the volume?' by pointing out again, as have others like myself, we are not going anywhere until we reduce the number of OS, imo, so we can attract institutional investors who are not going to buy an .18 stock